<html>
<head>PUBMED IDs for hepaCAM</head>
<body bgcolor='#C5F0F2'><h1>hepaCAM</h1><a href='https://pubmed.ncbi.nlm.nih.gov/15885354/'>Cloning and characterization of hepaCAM, a novel Ig-like cell adhesion molecule suppressed in human hepatocellular carcinoma.</a> May 12  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15917256/'>Structural and functional analyses of a novel ig-like cell adhesion molecule, hepaCAM, in the human breast carcinoma MCF7 cells.</a> May 27  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/18293412/'>GlialCAM, an immunoglobulin-like cell adhesion molecule is expressed in glial cells of the central nervous system.</a> February 23  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18845560/'>Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells.</a> October 11  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19507233/'>The immunoglobulin-like cell adhesion molecule hepaCAM induces differentiation of human glioblastoma U373-MG cells.</a> December 16  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20110109/'>Expression of hepaCAM and its effect on proliferation of tumor cells in renal cell carcinoma.</a> May 6  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20205955/'>Functional significance of the hepaCAM gene in bladder cancer.</a> April 13  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20593288/'>Expression and clinical significance of hepaCAM and VEGF in urothelial carcinoma.</a> November 5  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20628239/'>Exon 2 methylation inhibits hepaCAM expression in transitional cell carcinoma of the bladder.</a> February 24  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/23652371/'>The 786-0 renal cancer cell-derived exosomes promote angiogenesis by downregulating the expression of hepatocyte cell adhesion molecule.</a> January 8  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23652363/'>A Pro 12 Ala substitution in the PPARγ2 polymorphism may decrease the number of diseased vessels and the severity of angiographic coronary artery.</a> February 8  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23652361/'>Association between neuropeptide Y gene polymorphisms and alcohol dependence: a case-control study in two independent populations.</a> May 30  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23652326/'>Bacterial pathogenesis: Legionella makes its mark on histones.</a> March 7  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/26192362/'>Expression of hepaCAM inhibits bladder cancer cell proliferation via a Wnt/β-catenin-dependent pathway in vitro and in vivo.</a> September 13  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26192357/'>Rhesus immune responses to SIV Gag expressed by recombinant BCG vectors are independent from pre-existing mycobacterial immunity.</a> July 21  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26677113/'>5-azacytidine inhibits the proliferation of bladder cancer cells via reversal of the aberrant hypermethylation of the hepaCAM gene.</a> November 1  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26873485/'>The SMAD2/3 pathway is involved in hepaCAM-induced apoptosis by inhibiting the nuclear translocation of SMAD2/3 in bladder cancer cells.</a> February 22  2016<br></body></html>
